A Study of BBI503 in Adult Patients With Advanced Solid Tumors

Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors

NCT00618735 ·Status: COMPLETED ·Phase: PHASE1

BIBW 2992 in Patients With Advanced Solid Tumors

NCT02171650 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor

NCT03791112 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies

NCT01325441 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Weekly BI 836880 in Patients With Advanced Solid Tumors

NCT02689505 ·Status: COMPLETED ·Phase: PHASE1

This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)

NCT03604445 ·Status: TERMINATED ·Phase: PHASE1

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated

NCT05327946 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT05217693 ·Status: RECRUITING ·Phase: PHASE1

Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors

NCT02171663 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors

NCT06143007 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

NCT05155332 ·Status: SUSPENDED ·Phase: PHASE1

IBI308 in Subjects With Advanced/Metastatic Solid Malignancies

NCT03568539 ·Status: COMPLETED ·Phase: PHASE1

Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit

NCT02211859 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors

NCT05650242 ·Status: RECRUITING ·Phase: PHASE1

Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors

NCT02171728 ·Status: COMPLETED ·Phase: PHASE1

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425 ·Status: RECRUITING ·Phase: PHASE1

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

NCT02171702 ·Status: COMPLETED ·Phase: PHASE1

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT06241898 ·Status: RECRUITING ·Phase: PHASE1

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors

NCT02171637 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120

NCT00715403 ·Status: COMPLETED ·Phase: PHASE1

A Study of ABT-414 in Subjects With Solid Tumors

NCT01741727 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors

NCT06258408 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors

NCT06779851 ·Status: TERMINATED ·Phase: PHASE1

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

NCT03355066 ·Status: TERMINATED ·Phase: PHASE1

A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer

NCT01905111 ·Status: COMPLETED ·Phase: PHASE1